Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Return on Sales (2024 - 2025)

Silence Therapeutics' Return on Sales history spans 2 years, with the latest figure at 109.18% for Q4 2025.

  • For Q4 2025, Return on Sales fell 10988.0% year-over-year to 109.18%; the TTM value through Dec 2025 reached 147.3%, down 14634.0%, while the annual FY2025 figure was 121.97%, 12095.0% down from the prior year.
  • Return on Sales for Q4 2025 was 109.18% at Silence Therapeutics, up from 209.95% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.7% in Q4 2024 and bottomed at 209.95% in Q3 2025.